Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
16°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genprex Inc
(NQ:
GNPX
)
1.140
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,129
Open
1.140
Bid (Size)
1.070 (1)
Ask (Size)
1.280 (1)
Prev. Close
1.140
Today's Range
1.140 - 1.140
52wk Range
0.2806 - 14.40
Shares Outstanding
59,409,822
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
November 04, 2024
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
Exposures
Political
12 Health Care Stocks Moving In Monday's After-Market Session
October 28, 2024
Via
Benzinga
Performance
YTD
-87.82%
-87.82%
1 Month
-68.25%
-68.25%
3 Month
+62.81%
+62.81%
6 Month
-48.42%
-48.42%
1 Year
-88.97%
-88.97%
More News
Read More
12 Health Care Stocks Moving In Monday's Intraday Session
October 28, 2024
Via
Benzinga
Looking Into Genprex's Recent Short Interest
October 28, 2024
Via
Benzinga
GNPX Stock Earnings: Genprex Reported Results for Q2 2024
August 12, 2024
Via
InvestorPlace
GNPX Stock Earnings: Genprex Beats EPS for Q1 2024
May 20, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 23, 2024
Via
Benzinga
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 22, 2024
Via
Benzinga
Dow Falls Over 150 Points; General Motors Tops Q3 Views
October 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 22, 2024
Via
Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 21, 2024
Via
Benzinga
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
October 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
Planned Spin-Out to Focus on Gene Therapy for Type-1 and Type-2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex, Inc. (Nasdaq: GNPX)
September 04, 2024
Via
Get News
Positive Clinical Results with Promising Gene Therapy Treatment for Late Stage Lung Cancer; Life-Changing Developments for Cancer and Diabetes: Genprex, Inc. (Nasdaq: GNPX)
August 22, 2024
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
August 13, 2024
Via
Benzinga
Exposures
Fossil Fuels
S&P 500 Gains 1%; Home Depot Earnings Top Views
August 13, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
August 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
Clinical Trials Commenced for Promising Acclaim-3 Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer: Genprex, Inc. (NASDAQ: GNPX)
May 14, 2024
Via
Get News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.